|
Volumn 14, Issue 12, 2000, Pages 2267-2275
|
Improving outcome through two decades in childhood ALL in the Nordic countries: The impact of high-dose methotrexate in the reduction of CNS irradiation
a b c d e f g h i j |
Author keywords
Acute; Incidence; Leukemia; Long term follow up; Lymphocytic; Prognostic factors
|
Indexed keywords
ANTILEUKEMIC AGENT;
ASPARAGINASE;
CARMUSTINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
PREDNISONE;
TIOGUANINE;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER INCIDENCE;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURVIVAL;
CENTRAL NERVOUS SYSTEM DISEASE;
CHILD;
CHILDHOOD LEUKEMIA;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG MEGADOSE;
FEMALE;
HIGH RISK PATIENT;
HUMAN;
INFANT;
INFORMATION PROCESSING;
LEUKOCYTE COUNT;
MAJOR CLINICAL STUDY;
MALE;
POPULATION RESEARCH;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SCANDINAVIA;
SKULL IRRADIATION;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0038185593
PISSN: 08876924
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.leu.2401961 Document Type: Article |
Times cited : (246)
|
References (21)
|